Neumora Shares Plummet After Depression Drug Trial Fails
Neumora Therapeutics Inc. faces a setback as its depression drug, navacaprant, fails in a critical final-stage study, causing a sharp decline in shares.
Topic
depression treatment
A collection of 1 issue